Increased Framingham risk score associated with poor outcomes in people with multiple sclerosis

Takeaway

  • An increased Framingham risk score at baseline was associated with a greater risk of relapses, disability and escalation of disease-modifying treatment (DMT) in people with multiple sclerosis (MS).

Why this matters

  • The impact of multiple cardiovascular risk factors using the Framingham risk score in people with MS has not been assessed.

  • The results of this novel study may help with the long-term management of MS.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.